1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Exportin 1 Protein: new trials by email Literature Review of Exportin 1 Protein trials Research Report on Exportin 1 Protein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial) Selinexor Oral Tablet [Xpovio], R-CHOP Protocol - Diffuse Large B Cell Lymphoma | Phase 2 | Recruiting | Sun Yat-sen University | 42 | 2024-08-01 | 2026-02-12 |
| Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients Selinexor, R-CHOP Protocol - EBV-Positive Diffuse Large B-Cell Lymphoma, Nos | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 54 | 2022-11-01 | 2023-12-14 |
Lymphoma, Large B-Cell, Diffuse (1) · Pyloric Stenosis, Hypertrophic (1)
China (2)
QingQing Cai, MD. PhD. (1) · Rong Tao, MD. (1) · Yi Xia, MD. PhD. (1)